(Q43763634)

English

Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

0 references

fluticasone propionate

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

R Menendez

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

R H Stanford

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

L Edwards

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

C Kalberg

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

K Rickard

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

865-874

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

https://scigraph.springernature.com/pub.10.2165/00019053-200119080-00008

0 references

International trends in asthma mortality: 1970 to 1985.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11596838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ease of handling and clinical efficacy of fluticasone propionate Accuhaler/Diskus inhaler compared with the Turbohaler inhaler in paediatric patients. UK Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11596838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose inhaled corticosteroids and the prevention of death from asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11596838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An economic evaluation of asthma in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/11596838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhaled steroids and the risk of hospitalization for asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11596838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The costs of asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11596838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children

1 reference

https://pubmed.ncbi.nlm.nih.gov/11596838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluticasone propionate: an audit of outcomes and cost-effectiveness in primary care

1 reference

https://pubmed.ncbi.nlm.nih.gov/11596838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11596838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is high-dose fluticasone propionate via a metered-dose inhaler and Volumatic as efficacious as nebulized budesonide in adult asthmatics?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11596838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A national estimate of the economic costs of asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11596838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

US asthma mortality: 1941 to 1989.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11596838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Charge what you will ... reimbursements are shrinking

1 reference

https://pubmed.ncbi.nlm.nih.gov/11596838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11596838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of inhaled corticosteroid plus bronchodilator therapy versus bronchodilator monotherapy in children with asthma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11596838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost of asthma in the emergency department and hospital

1 reference

https://pubmed.ncbi.nlm.nih.gov/11596838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Explaining drug spending trends: does perception match reality?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11596838

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-200119080-00008

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43763634&oldid=2103129670"